Rituximab off label use for difficult-to-treat auto-immune diseases: reappraisal of benefits and risks (Q33378620)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab off label use for difficult-to-treat auto-immune diseases: reappraisal of benefits and risks |
scientific article |
Statements
1 reference
Rituximab off label use for difficult-to-treat auto-immune diseases: reappraisal of benefits and risks (English)
1 reference
Laurent Sailler
1 reference
1 February 2008
1 reference
1 reference
34
1 reference
103-110
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference